Showing results (101-110 of 486) with videos related to

Sort By:
Pageof 49
Transfusion Medicine (Oxford, England)|June 10, 2025
Extracorporeal photopheresis-New insights into an old procedureSabine Seiffert, Janine Kirchberg, Enrica Bach, et al.
Haematologica|June 24, 2009
Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cellsRebekka Wehner, Diana Wehrum, Martin Bornhäuser, et al.
BMC Cancer|May 21, 2022
Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studiesUwe Platzbecker, Joerg Chromik, Jan Krönke, et al.
Biomedicines|August 29, 2024
Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell PretreatmentAnja Grahnert, Sabine Seiffert, Kerstin Wenk, et al.
Transfusion|August 29, 2006
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myelomaFrank Kroschinsky, Kristina Hölig, Uwe Platzbecker, et al.
Blood|October 12, 2018
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopeniaMichael Dickinson, Honar Cherif, Pierre Fenaux, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trialUwe Platzbecker, Malte von Bonin, Eray Goekkurt, et al.
Frontiers in Oncology|February 4, 2022
Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case ReportLars Kurch, Thomas W Georgi, Astrid Monecke, et al.
Leukemia Research|December 6, 2011
Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshopUwe Platzbecker, Valeria Santini, Ghulam J Mufti, et al.
Frontiers in Oncology|May 3, 2021
Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid LeukemiaLeo Ruhnke, Friedrich Stölzel, Lisa Wagenführ, et al.
Pageof 49